CSF electrophoresis in one thousand patients

Area of Science:

• Neurology
• Immunology
• Clinical Diagnostics

Background:

• Multiple Sclerosis (MS) diagnosis relies on clinical presentation and supportive laboratory findings.
• Cerebrospinal fluid (CSF) analysis, including electrophoresis, can reveal intrathecal immunoglobulin synthesis characteristic of MS.
• Oligoclonal banding (O.B.) in CSF is a known biomarker associated with inflammatory neurological diseases.

Purpose of the Study:

• To evaluate the diagnostic utility of oligoclonal banding (O.B.) in cerebrospinal fluid (CSF) for multiple sclerosis (MS).
• To determine the prevalence of O.B. in patients with definite MS, possible MS, and other neurological diseases.
• To assess the reliability of CSF electrophoresis as a laboratory test for MS diagnosis.

Main Methods:

• Agarose and/or cellulose acetate electrophoresis performed on CSF samples from 1000 patients.
• Categorization of patients into clinically definite MS, possible MS, and other neurological diseases groups.
• Analysis of O.B. presence and correlation with clinical diagnosis and serum findings.

Main Results:

• Oligoclonal banding (O.B.) detected in 92.8% of definite MS patients (N=267).
• O.B. present in 31.1% of possible MS patients (N=283) and 8% of other neurological diseases (N=450).
• Identified 17 non-MS patients with unexplained O.B., where MS was not initially considered.

Conclusions:

• CSF electrophoresis demonstrating O.B. is a highly sensitive and specific marker for MS.
• The presence of O.B. in CSF significantly increases the likelihood of an MS diagnosis.
• CSF electrophoresis should be integrated into the diagnostic criteria for multiple sclerosis due to its reliability.